Peripheral vestibular disease can be treated with several approaches (e.g., maneuvers, surgery, or medical approach). Comorbidity is common in elderly patients, so polytherapy is used, but it can generate the development of drug–drug interactions (DDIs) that play a role in both adverse drug reactions and reduced adherence. For this reason, they need a complex kind of approach, considering all their individual characteristics. Physicians must be able to prescribe and deprescribe drugs based on a solid knowledge of pharmacokinetics, pharmacodynamics, and clinical indications. Moreover, full information is required to reach a real therapeutic alliance, to improve the safety of care and reduce possible malpractice claims related to drug–drug interactions. In this review, using PubMed, Embase, and Cochrane library, we searched articles published until 30 August 2021, and described both pharmacokinetic and pharmacodynamic DDIs in patients with vestibular disorders, focusing the interest on their clinical implications and on risk management strategies.

Drug–drug interactions in vestibular diseases, clinical problems, and medico-legal implications / Di Mizio G.; Marciano G.; Palleria C.; Muraca L.; Rania V.; Roberti R.; Spaziano G.; Piscopo A.; Ciconte V.; Di Nunno N.; Esposito M.; Viola P.; Pisani D.; De Sarro G.; Raffi M.; Piras A.; Chiarella G.; Gallelli L.. - In: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. - ISSN 1660-4601. - ELETTRONICO. - 18:24(2021), pp. 12936.1-12936.42. [10.3390/ijerph182412936]

Drug–drug interactions in vestibular diseases, clinical problems, and medico-legal implications

Raffi M.
;
Piras A.;
2021

Abstract

Peripheral vestibular disease can be treated with several approaches (e.g., maneuvers, surgery, or medical approach). Comorbidity is common in elderly patients, so polytherapy is used, but it can generate the development of drug–drug interactions (DDIs) that play a role in both adverse drug reactions and reduced adherence. For this reason, they need a complex kind of approach, considering all their individual characteristics. Physicians must be able to prescribe and deprescribe drugs based on a solid knowledge of pharmacokinetics, pharmacodynamics, and clinical indications. Moreover, full information is required to reach a real therapeutic alliance, to improve the safety of care and reduce possible malpractice claims related to drug–drug interactions. In this review, using PubMed, Embase, and Cochrane library, we searched articles published until 30 August 2021, and described both pharmacokinetic and pharmacodynamic DDIs in patients with vestibular disorders, focusing the interest on their clinical implications and on risk management strategies.
2021
Drug–drug interactions in vestibular diseases, clinical problems, and medico-legal implications / Di Mizio G.; Marciano G.; Palleria C.; Muraca L.; Rania V.; Roberti R.; Spaziano G.; Piscopo A.; Ciconte V.; Di Nunno N.; Esposito M.; Viola P.; Pisani D.; De Sarro G.; Raffi M.; Piras A.; Chiarella G.; Gallelli L.. - In: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. - ISSN 1660-4601. - ELETTRONICO. - 18:24(2021), pp. 12936.1-12936.42. [10.3390/ijerph182412936]
Di Mizio G.; Marciano G.; Palleria C.; Muraca L.; Rania V.; Roberti R.; Spaziano G.; Piscopo A.; Ciconte V.; Di Nunno N.; Esposito M.; Viola P.; Pisani D.; De Sarro G.; Raffi M.; Piras A.; Chiarella G.; Gallelli L.
File in questo prodotto:
File Dimensione Formato  
Di MIzio et al 2021.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 713.96 kB
Formato Adobe PDF
713.96 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/841574
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 7
social impact